Primary Site >> Liver Cancer

Gene >> SLC16A4

Journal: Mol Cells. 2013 Apr;35(4):335-41.
Title: Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.
Author: Jung, Yuri|Jang, Ye Jin|Kang, Min Ho|Park, Young Soo|Oh, Su Jin|Lee, Dong Chul|Xie, Zhi|Yoo, Hyang-Sook|Park, Kyung Chan|Yeom, Young Il
PMID: 23515579
Journal: World J Gastroenterol. 2014 Sep 7;20(33):11780-7.
Title: Characterization of monocarboxylate transporter activity in hepatocellular carcinoma.
Author: Alves, Venancio A|Pinheiro, Celine|Morais-Santos, Filipa|Felipe-Silva, Aloisio|Longatto-Filho, Adhemar|Baltazar, Fatima
PMID: 25206282
Journal: Clin Cancer Res. 2017 Jan 15;23(2):536-548.
Title: Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.
Author: Duran, Rafael|Mirpour, Sahar|Pekurovsky, Vasily|Ganapathy-Kanniappan, Shanmugasundaram|Brayton, Cory F|Cornish, Toby C|Gorodetski, Boris|Reyes, Juvenal|Chapiro, Julius|Schernthaner, Rudiger E|Frangakis, Constantine|Lin, MingDe|Sun, Jessica D|Hart, Charles
PMID: 27440271
Journal: Cancer Med. 2018 Oct 10.
Title: Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.
Author: Chen, Hai-Long|OuYang, Han-Yue|Le, Yong|Jiang, Peng|Tang, Hui|Yu, Zi-Shan|He, Min-Ke|Tang, Yun-Qiang|Shi, Ming
PMID: 30306706